Home > Insider Trading > Filing (0000014272-16-000313)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
14272	Bristol Myers Squibb Co	BMY	Pharmaceutical Preparations (2834)	220790350

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341069	C Joseph Caldarella	Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154	Svp & Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	Disposition	2016-03-04	12,962	$64.64	46,322	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.10 Par Value	Performance Shares	Acquisiton	2016-03-03	11,764	$0.00	11,764	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,764		2018-03-10	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.10 Par Value	1,707	Indirect	By BMY Savings and Investment Program

Footnotes

The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $64.64 to $64.68, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Based on a plan statement as of the end of the most recent fiscal quarter.
Each performance share converts into one share of common stock upon distribution in the first quarter of 2018, subject to a Total Shareholder Return modifier.
Represents performance shares earned under the 2015-2017 Long-Term Performance Award.